Acorda Therapeutics
ACOR
$0.66
Share price
0.00%
Change (1 day)
-21.31%
Change (1 year)
Categories
Acorda Therapeutics (ACOR) - P/B ratio
P/B ratio as of May 2024 : -0.0052
According to Acorda Therapeutics
's latest financial reports the company has a price-to-book ratio of -0.0052.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Acorda Therapeutics - P/B ratio (from 2006 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -0.1187 | -159.54% |
| 2022-12-31 | 0.1993 | 12.51% |
| 2021-12-31 | 0.1771 | 7.4% |
| 2020-12-31 | 0.1649 | -47.32% |
| 2019-12-31 | 0.3131 | -74.07% |
| 2018-12-31 | 1.21 | -37.4% |
| 2017-12-31 | 1.93 | 47.74% |
| 2016-12-31 | 1.31 | -57.2% |
| 2015-12-31 | 3.05 | -3.72% |
| 2014-12-31 | 3.17 | 16.84% |
| 2013-12-31 | 2.71 | 5.76% |
| 2012-12-31 | 2.56 | -44.38% |
| 2011-12-31 | 4.61 | -34.04% |
| 2010-12-31 | 6.99 | 0.37% |
| 2009-12-31 | 6.96 | 86.42% |
| 2008-12-31 | 3.73 | -62.25% |
| 2007-12-31 | 9.89 | -50.72% |
| 2006-12-31 | 20.1 | |
| 2005-12-31 | N/A | |
| 2003-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | 12.8 | -246,337.37% | 🇺🇸 USA |
 Repligen
RGEN | 4.70 | -90,480.41% | 🇺🇸 USA |
 Affimed
AFMD | 1.25 | -24,165.43% | 🇩🇪 Germany |
 BioMarin Pharmaceutical BMRN | 3.05 | -58,685.02% | 🇺🇸 USA |